[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343172-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343172-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","progress-pharmacokinetics-and-future-perspectives-of-luteolin-modulating-signaling-pathways-to-exert-anticancer-effects-a-review","Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects - A review","","Luteolin (3, 4, 5, 7-tetrahydroxyflavone) is a naturally occurring flavonoid in vegetables, fruits, and herbs, reported to show anti-tumor, anti-inflammatory, and antioxidant activity across cancers including lung, breast, prostate, and liver. Its anticancer effects involve coordinating multiple signaling pathways to trigger tumor-cell apoptosis, suppress proliferation and metastasis, limit angiogenesis, modulate immune function, reverse epithelial-mesenchymal transition, and adjust reactive oxygen species levels. The review consolidates recent findings and outlines future clinical application prospects, providing a theoretical basis and reference for further luteolin research.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/progress-pharmacokinetics-and-future-perspectives-of-luteolin-modulating-signaling-pathways-to-exert-anticancer-effects-a-review/343172/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/progress-pharmacokinetics-and-future-perspectives-of-luteolin-modulating-signaling-pathways-to-exert-anticancer-effects-a-review/343172.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What major anticancer mechanisms does luteolin regulate?","Question",{"text":63,"@type":64},"Luteolin modulates multiple signaling pathways to induce tumor-cell apoptosis, inhibit proliferation and metastasis, suppress angiogenesis, influence immune function, reverse epithelial-mesenchymal transition, and regulate reactive oxygen species levels.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cancers are mentioned as potential targets of luteolin?",{"text":68,"@type":64},"The text highlights effects in several cancer types, including lung, breast, prostate, and liver cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the purpose of the review in this document?",{"text":72,"@type":64},"It integrates recent research on luteolin and discusses future perspectives for clinical use, aiming to explain how luteolin exerts different anticancer effects through pathway regulation and to support future research directions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343172,1790619366,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","®  \n Narrative Review   \nProgress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects A review  \nRui Wang, MMa ,b , Xia Li, PhDc , Yanhan Xu, MMa , Yangyang Li, MMa , Weisong Zhang, MMa , Rongqi Guo, MMa , Jianxiang Song, PhDa ,*  \n\n| Abstract\u003Cbr>Luteolin (3, 4, 5, 7-tetrahydroxyflavone) are natural flavonoids widely found in vegetables, fruits and herbs, with anti-tumor, antiinflammatory and antioxidant effects, and also play an anti-cancer effect in various cancers such as lung, breast, prostate, and liver cancer, etc. Specifically, the anti-cancer mechanism includes regulation of various signaling pathways to induce apoptosis of tumor cells, inhibition of tumor cell proliferation and metastasis, anti-angiogenesis, regulation of immune function, synergistic anticancer drugs and regulation of reactive oxygen species levels of tumor cells. Specific anti-cancer mechanisms include regulation of various signaling pathways to induce apoptosis, inhibition of tumor cell proliferation and metastasis, anti-angiogenesis, reversal of epithelial-mesenchymal transition, regulation of immune function, synergism with anti-cancer drugs and regulation of reactive oxygen species levels in tumor cells. This paper integrates the latest cutting-edge research on luteolin and combines it with the prospect of future clinical applications, aiming to explore the mechanism of luteolin exerting different anticancer effects through the regulation of different signaling pathways, so as to provide a practical theoretical basis for the use of luteolin in clinical treatment and hopefully provide some reference for the future research direction of luteolin. |\n| --- |\n| Abbreviations: AKT = protein kinase B , cAMP = cyclic adenosine monophosphate, EMT = epithelial-mesenchymal transition, ERK = extracellular signal-regulated protein kinase, Fas = TNF Receptor Superfamily Member 6, GSK-3β = Glycogen Synthase Kinase-3β , IGF = insulin like growth factor, JAK/STAT = Janus kinase/signal transducer and activator of transcription, JNK = c-Jun N-terminal kinase, MAPK = mitogen-activated protein kinase, MMP = matrix metalloproteinase, NF-κB = nuclear factor Kappa-light-chain-enhancer of activated B cells, NPs = nanoparticles, PI3K = phosphatidylinositol 3-kinase, PKA = protein kinase A, PPS-PEG = poly(propylene sulfide)-poly(ethyleneglycol), ROS = reactive oxygen species, RSK = ribosomal S6 kinase, VEGF = vascular endothelial growth factor. |\n| Keywords: anti-cancer, immunity, luteolin, NPs, pharmacokinetics, signalling pathways |\n\n1. Introduction  \nMalignant tumors, as a multi-causal, systemic and complex disease, are characterized by uncontrolled cell proliferation and distant metastasis of cancer cells. According to statistics released by the World Health Organization (WHO), in 2020, China will have 4.57 million new cancer cases, accounting for  \n23.7% of the world total, and 3 million deaths, accounting for 30% of the world total. The number of new cases and deaths ranked first in the world, indicating that the burden of malignant tumors is significantly higher in China, and some studies have found that cancer has become the leading cause of death among Chinese urban and rural residents, and the incidence rate is increasing year by year.[1] Despite continuous  \nWR and LX contributed equally to this work.  \nThis research topic has been sponsored by the following fund projects:  \nPostgraduate Research and Practice Innovation Program of Jiangsu Province (no. SJCX24_2060), 2021 Jiangsu Provincial Health and Health Commission Medical Research Guidance Project (no. Z2021087), The Special Funds for Science Development of the Clinical Teaching Hospitals of Jiangsu Vocational College of Medicine (no. 20219105), 2021 Yancheng Medical Science and Technology Development Plan Project (no. YK2021060), Nantong University’s 2023 Academic Level Research Project (Special Project of Yancheng Third Institute) (no. YXYZ2023008","cbCaif87ppBKb4Vg","https://ap.wps.com/l/cbCaif87ppBKb4Vg","pdf",1275778,14,"English","# Abstract\n# Abbreviations\n# Introduction","[{\"question\":\"What major anticancer mechanisms does luteolin regulate?\",\"answer\":\"Luteolin modulates multiple signaling pathways to induce tumor-cell apoptosis, inhibit proliferation and metastasis, suppress angiogenesis, influence immune function, reverse epithelial-mesenchymal transition, and regulate reactive oxygen species levels.\"},{\"question\":\"Which cancers are mentioned as potential targets of luteolin?\",\"answer\":\"The text highlights effects in several cancer types, including lung, breast, prostate, and liver cancer.\"},{\"question\":\"What is the purpose of the review in this document?\",\"answer\":\"It integrates recent research on luteolin and discusses future perspectives for clinical use, aiming to explain how luteolin exerts different anticancer effects through pathway regulation and to support future research directions.\"}]","Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects - A review | PDF",1790050169,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16319b1276bdf7da0cbbc657aa11dc80.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95f1c6a6d51d47a3fd7d98953974380d.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdff6c45c2d5d424fe725f2d44e9f239.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b43abbd1e0fa3c263a159c377271ea3.webp",980,1306]